Anzeige
Mehr »
Login
Samstag, 06.03.2021 Börsentäglich über 12.000 News von 657 internationalen Medien
Bam Bam Resources und die Mega-Kupferlagerstätte in Teslas Hinterhof!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JN62 ISIN: US04522R1014 Ticker-Symbol: 7A9 
Tradegate
05.03.21
18:28 Uhr
2,660 Euro
-0,140
-5,00 %
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
ASLAN PHARMACEUTICALS LTD ADR Chart 1 Jahr
5-Tage-Chart
ASLAN PHARMACEUTICALS LTD ADR 5-Tage-Chart
RealtimeGeldBriefZeit
2,8802,94005.03.
2,8202,98005.03.

Aktuelle News zur ASLAN PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoASLAN Pharmaceuticals Ltd - 6-K, Report of foreign issuer1
MiAslan Pharma secures $60M capital raise2
MiASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary Shares5
ASLAN PHARMACEUTICALS Aktie jetzt für 0€ handeln
MoASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares4
MoASLN Stock: Why Aslan Pharmaceuticals Is Up 20% Today4
MoAslan Pharma price target raised to a Street-high at Piper Sandler2
MoAslan Pharma Jumps on Progress With Dermatitis Treatment-
MoStock Alert: ASLAN Pharma Jumps 30% On Positive Data From Atopic Dermatitis Treatment Study2
MoAslan Pharmaceuticals Shares Are Trading Higher On Positive ASLAN004 Data In Atopic Dermatitis1
MoAslan Pharma's ASLAN004 shows positive effect in atopic dermatitis5
MoASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Announces Positive Interim Data From the Multiple Ascending Dose Study of ASLAN004 in Atopic Dermatitis7
26.02.ASLAN Pharmaceuticals announces $18m private placement3
25.02.ASLAN Pharmaceuticals jumps 28% on $18M private placement1
25.02.ASLAN Pharmaceuticals Ltd - 6-K, Report of foreign issuer-
25.02.ASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Announces $18 Million Private Placement1
18.02.ASLAN Pharmaceuticals Ltd - 6-K, Report of foreign issuer2
18.02.ASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Appoints Dr Neil Graham as Independent Director2
26.01.ASLAN Pharma's ASLAN003 potentially least hepatotoxic, preclinical study shows4
26.01.ASLAN PHARMACEUTICALS LIMITED: New Research Published in Toxicology in Vitro Provides Insight Into the Hepatotoxicity of DHODH Inhibitors Suggesting ASLAN003 ...-
15.01.ASLAN Pharmaceuticals Ltd - S-8, Securities to be offered to employees in employee benefit plans1
Seite:  Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1